UK
Osteoporisis risk in over half of European women over 70, three-quarters not treated, Amgen study finds
April 8, 2019Research and Development, Sales and Marketing Amgen, Europe, UK, bones, osteoporosis, pharma, real world data, real-world data
A new study from Amgen analysing real-world data has revealed that more than half of European women over 70 years …
Top Ten most popular articles on Pharmafile.com this week!
April 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, Northern Ireland, Novartis, Placebo, UK, brexit, pharma
As Brexit looms, pharma trade lobby the ABPI called for a ban on exports of medicines in the case of …
BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund
April 5, 2019Medical Communications, Sales and Marketing CDF, Cancer, Cancer Drugs Fund, Kidney cancer, NICE, UK, Yervoy, opdivo
NICE has revealed it is recommending that Bristol-Myers Squibb’s Opdivo (nivolumab), in combination with Yervoy (ipilimumab), be made available to …
England’s antidepressant prescriptions double to 70m in a decade
March 29, 2019Medical Communications England, UK, antidepressants, anxiety, depression, pharma
Figures released by NHS Digital have revealed that prescriptions for antidepressants in the UK have risen to 70.9 million, almost …
ABPI calls for temporary export ban in effort to prevent shortages in case of no-deal Brexit
March 29, 2019Medical Communications ABPI, UK, brexit, drug shortages, export market
The Association of the British Pharmaceutical Industry (ABPI) has called for a temporary ban on exports as a means of …
Vertex destroyed nearly 8,000 packs of Orkambi in 2018
March 28, 2019Medical Communications, Sales and Marketing Briatin, Orkambi, UK, Vertex, cystic fibrosis
Vertex destroyed nearly 8,000 packs of the $272,000 a year cystic fibrosis drug Orkambi in 2018, the company said in …
AstraZeneca’s Imfinzi to be made available via Cancer Drugs Fund in England
March 28, 2019Sales and Marketing AstraZeneca, Cancer, Imfinzi, NHS, NICE, UK, lung cancer
AstraZeneca’s PD-L1 inhibitor Imfinzi (durvalumab) will now be made available to English lung cancer patients on the NHS via the …
Sanofi may airlift flu vaccines into UK after Brexit
March 26, 2019Manufacturing and Production EU, France, Sanofi, UK, brexit, channel tunnel, vaccines
French firm Sanofi would airlift flu vaccines into the UK in the case of a highly disruptive exit from the …
NICE recommend Takeda’s lymphoma treatment Adcetris
March 25, 2019Sales and Marketing Cancer, NICE, Takeda, UK, lymphoma, oncology, recommendation
Britain’s cost effectiveness body has recommended Takeda’s Adcetris (brentuximab vedotin) for adult patients with CD-30 positive advanced cutaneous T-cell lymphoma …
Breast cancer mortality rates fall faster in Britain than elsewhere in Europe
March 19, 2019Manufacturing and Production, Research and Development Cancer, EU, Europe, France, Italy, Poland, UK, breast cancer, german, oncology
Death rates from breast cancer are falling faster in Britain than in any of the other six most populous countries …
Scottish Medicines Consortium rejects Novartis’ CAR T therapy Kymriah
March 12, 2019Manufacturing and Production Kymriah, NICE, Novartis, SMC, Scotland, UK
Scotland’s cost effectiveness body has refused to fund Novartis’ CAR T therapy Kymriah for adult patients with lymphoma. The Scottish …
Measles cases in Greater Manchester surge to 32 since January, lack of vaccination blamed
March 8, 2019Medical Communications Europe, MMR, UK, WHO, measles, pharma, vaccines
There has been a sharp increase in cases of measles across Greater Manchester, Public Health England has warned, following increasingly …
Public satisfaction with NHS falls to lowest point since 2007
March 7, 2019Medical Communications England, King's, NHS, Nuffield, Scotland, UK, Wales, kings, public stisfaction
Public satisfaction with the NHS has fallen to lowest levels since 2007, according to analysis of the 2018 British Social …
Top Ten most popular articles on Pharmafile.com this week!
March 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10
As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …
More than 40% of GPs intend to quit within five years
February 28, 2019Medical Communications GPs, NHS, NHS LOng term plan, UK, brexit, workforce
More than 40% of GPs intend to quit within five years according to researchers at the University of Warwick. The …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
